Development Stages Sample Clauses

Development Stages. In Kvemo Kartli, on the historical territory of Bolnisi a German settlement under the name of Katerinenfeld was established from 1818. With the “support” of the government of Russian Empire, in 1816-18 German people from Württemberg - “Schwabes” were moved to Southern Georgia. In 1818, about 500 families established 8 colonies near Tbilisi, among which the largest settlement was Katerinenfeld, where 95 households lived. Since 1818, the city type town has changed its name for several times. From 1818 up to 1921 it was called Katerinenfeld, from 1921 until 1943 – Luxemburg, and from 1943 its old name was reestablished and it returned its historical name – Bolnisi.
AutoNDA by SimpleDocs
Development Stages. The complete infrastructure can be developed in not more than 3 phases as follows – Phase 1 : Within 18 months from the date of Agreement to LeasePhase 2 and Phase 3: Within 4 years of the date of the Agreement to Lease. – Intra-phase milestones as laid down in this agreement and/or the Amaravati Land Allotment Policy documents shall be followed – Physical infrastructure targets including buildings, roads, playgrounds etc., shall be as per follows: □ Phase 1: 30,000 sq ft of Built Up area □ Phase 2 and Phase 3: Combined development of the balance built up area and facilities ■ Sports and other Infrastructure Facilities – School shall keep 50% of the allotted plot for open use activities like outdoor sports activities etc. – 100% full FSI of the plot should be developed within 4(Four) years of date of Agreement to Lease. – Availability of minimum 3 outdoor sports and games facilities and minimum 3 indoor sports and games facilities within 4 (Four) years of date of Agreement to Lease. – School should have a well-built library and facilities for group discussions, individual learning and online tool access. Number of titles per student should be minimum 7.5
Development Stages. The development stages for Development of the Products under this Agreement shall be as set forth below (each, a “Development Stage”).
Development Stages. Stage Key output Target Completion [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] [**] Schedule 3 – Generic Program IP Following is a list of Generic Program Intellectual Property included for clarity on this issue. General engineering principles and know-how related to: Confidential Materials omitted and filed separately with the Securities and Exchange Commission. A total of one page was omitted. [**] Schedule 4 – Invetech Key Personnel [**] Schedule 5Specialist Program IP Specialist Program Intellectual Property existing as of the Effective Date includes (unless specifically listed as Generic Program IP in Schedule 3), but is not limited to: [**]. Schedule 6 – Invetech Intellectual Property Refer document: Invetech Cellular IP items D4.pdf Confidential Materials omitted and filed separately with the Securities and Exchange Commission. A total of eight pages were omitted. [**] Signing page EXECUTED as an agreement.
Development Stages. The development of the Product shall commence when an agreement concerning the SPECIFICATION is reached; it shall end when the PROTOTYPES are approved by PowerDsine. The development comprises the following phases: ------------------------------- ------------------------- ------------ RESPONSIBILITY DURATION ------------------------------- ------------------------- ------------ Development of the Product including simulation Austria Mikro Systeme [**] ------------------------------- ------------------------- ------------ Production of the ENGINEERING SAMPLES Austria Mikro Systeme [**] ------------------------------- ------------------------- ------------ Approval of the ENGINEERING SAMPLES PowerDsine [**] ------------------------------- ------------------------- ------------ Production of the PROTOTYPES Austria Mikro Systeme [**] ------------------------------- ------------------------- ------------ Approval of the PROTOTYPES PowerDsine [**] ------------------------------- ------------------------- ------------
Development Stages. Website Development Work stages Hours
Development Stages. The complete infrastructure can be developed in not more than 3 phases as follows – Phase 1 : Within 18 months from the date of Agreement to LeasePhase 2 and Phase 3 : Within 4 years of the date of the Agreement to Lease. – Intraphase milestones as laid down in the Amaravati Land Allotment Policy documents shall be followed – Physical targets including buildings, roads, playgrounds shall be as per follows: □ Phase 1: 30,000 sq ft of Academic and 25,000 Sq ft of Residential Built Up area □ Phase 2 and Phase 3: Combined development of the balance built up area ■ Sports and other Infrastructure Facilities – School shall keep 50% of the allotted plot for open use activities like outdoor sports activities etc. – Availability of minimum 3 outdoor sports and games facilities and minimum 3 indoor sports and games facilities within 4 (Four) years of date of Agreement to Lease. – School should have a well-built library for group discussions, individual learning and online tool access section. Number of titles/student should be minimum 7.5
AutoNDA by SimpleDocs
Development Stages 

Related to Development Stages

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Development Diligence Novartis shall dedicate commercially reasonable efforts, during each [**] month period, necessary to continue the advancement of Licensed Compounds and Licensed Products with respect to at least one Profile towards the next clinical Development milestone or approval milestone, as described in Sections 7.4.2 or 7.4.3, respectively. If Novartis (itself or through its Affiliates or sublicensees) fails to dedicate commercially reasonable efforts, during any [**] month period, necessary to continue the advancement of Licensed Compounds and Licensed Products with respect to at least one Profile towards such next milestone, then any dispute regarding Novartis’ failure of development diligence with respect to such Profile shall be resolved in accordance with Article 13.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development Efforts 4.2.1 Hana shall use Commercially Reasonable Efforts to Develop each Product in the Territory (including carrying out its responsibilities under the Development Plan) to:

  • Development Plans 4.3.1 For each Licensed Indication and corresponding Licensed Product in the Field, Licensee will prepare and deliver to Licensor a development plan and budget (each a “Development Plan”). The initial Development Plans for each Licensed Indication will be delivered within […***…] after the Grant Date for such Licensed Indication.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Commercialization Diligence Novartis shall dedicate commercially reasonable efforts, during each [**] month period, necessary to commercialize a Licensed Product for a Profile, after receipt of Regulatory Approval therefor, in any of the U.S., Japan or the EU Major Market Countries. If Novartis commercializes a Licensed Product for a Profile, after receipt of Regulatory Approval therefor, in any of the U.S., Japan or the EU Major Market Countries, Novartis will be deemed to satisfy all diligence obligations with respect to such Profile.

Time is Money Join Law Insider Premium to draft better contracts faster.